VI Partners — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Xeltisxeltis.comin𝕏Aug 2026
Xeltis is a medtech company developing bioresorbable vascular implants, such as its aXess conduit for hemodialysis access, that are gradually replaced by the patient's own living tissue.
BiotechHealthtechMedical Devices
Eliane Schutte(CEO)
Co-investorsKurma PartnersYsios CapitalEQT Life SciencesInvest-NL
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.